Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial()()

OBJECTIVE: To describe medroxyprogesterone acetate (MPA) levels among Kenyan depot medroxyprogesterone acetate (DMPA) users in the FEM-PrEP HIV prevention trial, and to compare MPA levels between ARV for HIV prevention (treatment) and placebo groups. STUDY DESIGN: We measured MPA in previously colle...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanda, Kavita, Callahan, Rebecca, Taylor, Douglas, Wang, Meng, Agot, Kawango, Jenkins, David, Van Damme, Lut, Dorflinger, Laneta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894753/
https://www.ncbi.nlm.nih.gov/pubmed/26972780
http://dx.doi.org/10.1016/j.contraception.2016.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894753/
https://www.ncbi.nlm.nih.gov/pubmed/26972780
http://dx.doi.org/10.1016/j.contraception.2016.03.003

Ejemplares similares